Ketamine Clinical Trials
Pre-hospital Care With Intra-Nasal Ketamine for Transport (PRECINKT): A Pilot Study
To see complete record on clinicaltrials.gov, please visit this link
Id: NCT02033434
Organisation Name: University of Calgary
Overal Status: Completed
Start Date: March 1, 2014
Last Update: September 26, 2019
Lead Sponsor: University of Calgary
Brief Summary: The investigators hypothesize that intra-nasal ketamine, for analgesia of patients with moderate to severe pain in an alpine setting, will provide a clinically significant reduction in pain and provide an effective and feasible alternative to intravenous opioids.
The investigators wish to know:
Is our study protocol feasible to study INK in a mountain, prehospital care environment?
What estimate can be made of recruitment rates?
Does studying the use of INK interfere with or delay care at Whistler/Blackcomb?
Is intra-nasal ketamine an effective and safe method for controlling pain in our study population and setting?
Does intranasal ketamine provide a clinically significant reduction in pain or do patients require additional IV narcotics for extraction?
Are there any significant changes in vital signs after administration of intra-nasal ketamine
Does the use of intra-nasal ketamine reduce time of patient extraction and transport in the alpine pre-hospital setting?
Are there any long term sequelae of INK at one week?
Conditions:
- Pain
- Traumatic Limb Injury
Total execution time in seconds: 0.20868015289307